Discussing and analyzing the differences in pathway enrichment and gene mutations between high and low CDI groups may help reveal those molecular mechanisms underlying the CDI in SOC, helping to clarify the working principles of the CDI, optimize the accuracy of the prediction model, characterize more potential mechanisms and prognostic markers, and provide directions for improving PPPM in SOC. The gene discussed is UBXN11; the disease is clostridium difficile infection.